Tower Research Capital (TRC)’s Azora Therapeutics AZR Stock Holding History
Bought
Maintained
Sold
Other funds holding AZR
Tower Research Capital (TRC)'s AZR Position: Q3 2026 in Review
Tower Research Capital (TRC) increased its Azora Therapeutics (AZR) stake by 25% in Q3 2026, buying an estimated $1.54K and bringing the position to 1,777 shares worth $7.13K. The position accounts for ﹤0.01% of the portfolio, ranked #4492.
Tower Research Capital (TRC) first reported a position in AZR in Q3 2018 and has held it in 19 quarters since. The position peaked at $11K in Q1 2022. 22 funds tracked by Wall St. Rank hold AZR as of Q3 2026.
- Tower Research Capital (TRC) held 1,777 shares of Azora Therapeutics worth $7.13K as of Q3 2026.
- Tower Research Capital (TRC) bought 358 Azora Therapeutics shares in Q3 2026, an estimated $1.54K.
- Azora Therapeutics made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q3 2026, its #4492 holding.
- Tower Research Capital (TRC) first reported a position in Azora Therapeutics in Q3 2018 and has held it in 19 quarters since.
- Tower Research Capital (TRC)'s Azora Therapeutics position peaked at $11K in Q1 2022.
- 22 funds tracked by Wall St. Rank held Azora Therapeutics as of Q3 2026.
Based on Tower Research Capital (TRC)'s 13F filing for Q3 2026, filed 16 Nov 2026.